This study is intended to investigate the safety and efficacy of ω-3 polyunsaturated fatty acid-based parenteral nutrition (PN) for patients with Crohn's disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
158
CD patients are divided into two groups, which include with and without ω-3 polyunsaturated fatty acid-based PN (0.1-0.2g/kg/d).
Patients receive bowel resection due to complications of Crohn's Disease
Sir Run Run Shaw hospital
Hangzhou, Zhejiang, China
RECRUITINGRate of Postoperative complications
postoperative complications after surgery for Crohn's Disease according to clavien-dindo system
Time frame: postoperative 1-30 days
Length of postoperative hospital stay
postoperative hospital stay after surgery for Crohn's Disease
Time frame: from surgery to discharge
Blood Concentration of IL-6
Blood Concentration of IL-6 after surgery
Time frame: postoperative 1, 3, and 6 day
Blood Concentration of TNF-α
Blood Concentration of TNF-α after surgery
Time frame: postoperative 1, 3, and 6 day
Blood Concentration of IL-1β
Blood Concentration of IL-1β after surgery
Time frame: postoperative 1, 3, and 6 day
Blood Concentration of albumin
Blood Concentration of albumin after surgery
Time frame: postoperative 1, 3, and 6 day
Blood Concentration of C-reactive protein
Blood Concentration of C-reactive protein after surgery
Time frame: postoperative 1, 3, and 6 day
Blood White blood cell level
Blood White blood cell level after surgery
Time frame: postoperative 1, 3, and 6 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.